Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
There is a current lack of treatment interventions for neuropathy and neuronal regeneration. VM202 presents a promising option for HGF agents as analgesics. By Kat Houlihan, PharmD Candidate and Jayne Pawasauskas, PharmD, BCPS Diabetic Peripheral Neuropathy Medications: A Background Diabetic peripheral neuropathy (DPN) is a progressive, quality of life-diminishing consequence of diabetes due to symptoms of debilitating pain and interference of sleep.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
